Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of depleting target antigen-specific antibody from a patient by administering a fusion protein (Seldeg) for selectively depleting antigen-specific antibodies

Method of depleting target antigen-specific antibody from a patient by administering a fusion protein (Seldeg) for selectively depleting antigen-specific antibodies

US Patent 12404339 · Granted Sep 2, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Endolysosomal targeting conjugates for improved delivery of cargo molecules to t2023
Fusion proteins (Seldegs) for selectively depleting antigen-specific antibodies 2022
Fusion proteins (Seldegs) for selectively depleting antigen-specific antibodies 2022
Fusion proteins (Seldegs) for selectively depleting antigen-specific antibodies 2022
Targeting HER2 and HER3 with bispecific antibodies in cancerous cells2019